RXO, Inc. RXO

$28.54 -0.38% at last close

Analyst Consensus

Consensus Rating
Hold (5 Buy · 11 Hold · 0 Sell)
Average Price Target
$26.68
Implied Upside
-6.5%
Price Target Range
$15.00 – $35.00
Analysts (12 mo)
16

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-10-06
CitigroupAriel Rosa
Maintains Neutral $23 → $30
2026-10-06
TD CowenJason Seidl
Upgrades Sell → Hold $18 → $30
2026-10-06
Wells FargoChristian Wetherbee
Maintains Equal-weight $23 → $30
2026-10-06
JP MorganBrian Ossenbeck
Upgrades Underweight → Neutral $22 → $30
2026-10-06
JefferiesStephanie Moore
Downgrades Buy → Hold $30
2026-09-23
SusquehannaHarrison Bauer
Upgrades Negative → Neutral $20 → $19
2026-09-09
Wells FargoChristian Wetherbee
Maintains Equal-weight $22 → $23
2026-08-07
UBSThomas Wadewitz
Maintains Neutral $26 → $23
2026-08-07
TD CowenJason Seidl
Maintains Sell $19 → $18
2026-08-07
CitigroupAriel Rosa
Maintains Neutral $30 → $23
2026-08-07
CitizensJeff Kauffman
Upgrades Market perform → Market outperform $30
2026-08-07
Truist SecuritiesLucas Servera
Maintains Buy $30 → $28
2026-07-28
TD CowenJason Seidl
Downgrades Hold → Sell $24 → $19
2026-07-16
Goldman SachsJordan Alliger
Maintains Neutral $18 → $20
2026-07-15
Truist SecuritiesLucas Servera
Maintains Buy $26 → $30
2026-07-14
SusquehannaBascome Majors
Maintains Negative $18 → $20
2026-07-14
BMO CapitalFadi Chamoun
Initiates coverage on Outperform $35
2026-07-13
StifelJ. Bruce Chan
Maintains Buy $22 → $30
2026-07-09
CitigroupAriel Rosa
Maintains Neutral $24 → $30
2026-06-30
UBSThomas Wadewitz
Maintains Neutral $22 → $26
2026-06-26
BarclaysBrandon Oglenski
Maintains Overweight $20 → $28
2026-05-15
StifelJ. Bruce Chan
Upgrades Hold → Buy $22
2026-05-08
UBSThomas Wadewitz
Maintains Neutral $17 → $22
2026-05-08
CitigroupAriel Rosa
Maintains Neutral $17 → $24
2026-05-08
Truist SecuritiesLucas Servera
Maintains Buy $20 → $26
2026-05-08
BarclaysBrandon Oglenski
Maintains Overweight $17 → $20
2026-05-08
Wells FargoChristian Wetherbee
Maintains Equal-weight $15 → $22
2026-05-08
SusquehannaBascome Majors
Maintains Negative $14 → $18
2026-05-08
Morgan StanleyRavi Shanker
Downgrades Overweight → Equal-weight $19 → $22
2026-04-22
SusquehannaBascome Majors
Maintains Negative $12 → $14

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$28.54
Market Cap
$4.73 billion
52-Week Range
$10.43 – $29.90
Average Volume
2.57 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.